NAV Price | $20.70 |
NAV Daily Change ($) | $0.33 |
NAV Daily Change (%) | 1.62% |
NAV YTD Return | 2.27% |
Market Price | $20.68 |
Market Daily Change ($) | $0.31 |
Market Daily Change (%) | 1.52% |
Market YTD Return | 2.17% |
Inception Date | 11/16/2022 |
Expense Ratio (%) | 0.80% |
Total Net Assets (million) | $3.623 |
Shares Outstanding | 175,000 |
Ticker | MEDI |
Cusip | 41151J869 |
ISIN | US41151J896 |
Benchmark | Russell 3000® Growth Health Care Index |
Exchange | NYSE |
Distributor | Foreside Fund Services, LLC |
Investment Objective | The Fund seeks long-term growth of capital. |
Morningstar Category | Health |
Dividend Frequency | Annually |
"Health care is a sector that we are very passionate about, and one in which we have a strong history."
Matthew R. Renna
Partner, Portfolio Manager, Westfield Capital Management Company L.P.
12/21/2022
12/22/2022
12/27/2022
--
--
--
0.00000
UNITEDHEALTH GROUP INC COMMON STOCK USD.01 [UNH]
Equity
UNITED STATES
91324P102
1,001
499.19
499,689.19
13.8
ELI LILLY + CO COMMON STOCK [LLY]
Equity
UNITED STATES
532457108
1,190
344.15
409,538.50
11.3
ASCENDIS PHARMA A/S ADR ADR DKK1.0 [ASND]
Equity
DENMARK
04351P101
2,527
124.08
313,550.16
8.7
ICON PLC COMMON STOCK EUR.06 [ICLR]
Equity
IRELAND
G4705A100
966
230.71
222,865.86
6.2
ALKERMES PLC COMMON STOCK USD.01 [ALKS]
Equity
IRELAND
G01767105
6,213
28.64
177,940.32
4.9
THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0 [TMO]
Equity
UNITED STATES
883556102
299
570.33
170,528.67
4.7
LANTHEUS HOLDINGS INC COMMON STOCK USD.01 [LNTH]
Equity
UNITED STATES
516544103
2,868
57.50
164,910.00
4.6
BIO RAD LABORATORIES A COMMON STOCK USD.0001 [BIO]
Equity
UNITED STATES
090572207
329
467.46
153,794.34
4.2
ABBVIE INC COMMON STOCK USD.01 [ABBV]
Equity
UNITED STATES
00287Y109
930
147.75
137,407.50
3.8
DEXCOM INC COMMON STOCK USD.001 [DXCM]
Equity
UNITED STATES
252131107
1,238
107.09
132,577.42
3.7
MERCK + CO. INC. COMMON STOCK USD.5 [MRK]
Equity
UNITED STATES
58933Y105
1,130
107.41
121,373.30
3.4
CATALENT INC COMMON STOCK USD.01 [CTLT]
Equity
UNITED STATES
148806102
1,727
53.55
92,480.85
2.6
IDEXX LABORATORIES INC COMMON STOCK USD.1 [IDXX]
Equity
UNITED STATES
45168D104
173
480.50
83,126.50
2.3
SAREPTA THERAPEUTICS INC COMMON STOCK USD.0001 [SRPT]
Equity
UNITED STATES
803607100
665
124.97
83,105.05
2.3
AVANTOR INC COMMON STOCK USD.01 [AVTR]
Equity
UNITED STATES
05352A100
3,353
23.90
80,136.70
2.2
VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01 [VRTX]
Equity
UNITED STATES
92532F100
239
323.10
77,220.90
2.1
AMEDISYS INC COMMON STOCK USD.001 [AMED]
Equity
UNITED STATES
023436108
777
96.66
75,104.82
2.1
INSULET CORP COMMON STOCK USD.001 [PODD]
Equity
UNITED STATES
45784P101
231
287.32
66,370.92
1.8
INSPIRE MEDICAL SYSTEMS INC COMMON STOCK USD.001 [INSP]
Equity
UNITED STATES
457730109
238
253.06
60,228.28
1.7
COOPER COS INC/THE COMMON STOCK USD.1 [COO]
Equity
UNITED STATES
216648402
167
348.93
58,271.31
1.6
VERADIGM INC COMMON STOCK USD.01 [MDRX]
Equity
UNITED STATES
01988P108
2,912
17.91
52,153.92
1.4
ROCKET PHARMACEUTICALS INC COMMON STOCK USD.01 [RCKT]
Equity
UNITED STATES
77313F106
2,261
21.73
49,131.53
1.4
PROMETHEUS BIOSCIENCES INC COMMON STOCK USD.0001 [RXDX]
Equity
UNITED STATES
74349U108
390
113.66
44,327.40
1.2
APELLIS PHARMACEUTICALS INC COMMON STOCK USD.0001 [APLS]
Equity
UNITED STATES
03753U106
777
52.73
40,971.21
1.1
HAEMONETICS CORP/MASS COMMON STOCK USD.01 [HAE]
Equity
UNITED STATES
405024100
447
84.60
37,816.20
1.0
OPTION CARE HEALTH INC COMMON STOCK USD.0001 [OPCH]
Equity
UNITED STATES
68404L201
1,169
28.87
33,749.03
0.9
SEAGEN INC COMMON STOCK USD.001 [SGEN]
Equity
UNITED STATES
81181C104
217
139.48
30,267.16
0.8
NEUROCRINE BIOSCIENCES INC COMMON STOCK USD.001 [NBIX]
Equity
UNITED STATES
64125C109
244
110.93
27,066.92
0.7
AZENTA INC COMMON STOCK USD.01 [AZTA]
Equity
UNITED STATES
114340102
427
55.90
23,869.30
0.7
KARUNA THERAPEUTICS INC COMMON STOCK USD.00001 [KRTX]
Equity
UNITED STATES
48576A100
97
199.39
19,340.83
0.5
BICYCLE THERAPEUTICS PLC ADR ADR USD.01 [BCYC]
Equity
UNITED KINGDOM
088786108
651
27.62
17,980.62
0.5
QUEST DIAGNOSTICS INC COMMON STOCK USD.01 [DGX]
Equity
UNITED STATES
74834L100
121
148.48
17,966.08
0.5
ARCUTIS BIOTHERAPEUTICS INC COMMON STOCK USD.0001 [ARQT]
Equity
UNITED STATES
03969K108
847
16.57
14,034.79
0.4
REPLIGEN CORP COMMON STOCK USD.01 [RGEN]
Equity
UNITED STATES
759916109
56
185.30
10,376.80
0.3
INNOVIVA INC COMMON STOCK USD.01 [INVA]
Equity
UNITED STATES
45781M101
662
12.65
8,374.30
0.2
Total
--
--
--
--
--
3,608
99.6
Cash and Other Assets Less Liabilities
--
--
--
--
--
--
0.4
Total Net Assets
--
--
--
--
--
--
100%
Sorry, there is no data available for this fund
Sorry, there is no data available for this fund
Westfield Capital Management Company, L.P. is dedicated to providing strong and consistent investment performance based on a disciplined, team-based approach, with exceptional client service. Westfield believes their greatest strength comes from the collective wisdom of a fully engaged and inspired team working together with clear objectives. Additionally, Westfield embraces their partnership structure, which aligns the advancement of the organization with their clients and serves to attract and retain exceptional talent.
Investing involves risk, principal loss is possible. Unlike mutual funds, ETFs may trade at a premium or discount to their net asset value. Harbor ETFs are new and have limited operating history to judge.
There is no guarantee that the investment objective of the Fund will be achieved. Stock markets are volatile and equity values can decline significantly in response to adverse issuer, political, regulatory, market and economic conditions. Since the Fund may hold foreign securities, it may be subject to greater risks than funds invested only in the U.S. These risks are more severe for securities of issuers in emerging market regions. Foreign currencies can decline in value and can adversely affect the dollar value of the fund. Since the Fund typically invests in a limited number of companies, an adverse event affecting a particular company may hurt the Fund's performance more than if it had invested in a larger number of companies. Authorized Participant Concentration/Trading Risk: Only authorized participants (“APs”) may engage in creation or redemption transactions directly with the Fund. The Fund is classified as non-diversified, a non-diversified Fund may invest a greater percentage of its assets in securities of a single issuer, and/or invest in a relatively small number of issuers, it is more susceptible to risks associated with a single economic, political or regulatory occurrence than a more diversified portfolio. New Fund Risk: There can be no assurance that the Fund will grow to or maintain an economically viable size, in which case the Board of Trustees may determine to liquidate the Fund. Small and Mid Cap Risk: The Fund’s performance may be more volatile because it may invest in issuers that are smaller companies.
Shares are bought and sold at market price not net asset value (NAV). Market price returns are based upon the closing composite market price and do not represent the returns you would receive if you traded shares at other times.
Weighted Average Market Capitalization: The average size of the companies in a portfolio or index as measured by the market value of outstanding shares.
Price/Book: The price-to-book (P/B) ratio evaluates a firm's market value relative to its book value.
Adjusted Trailing P/E Ratio: The Adjusted Trailing P/E (Price/Earnings) Ratio is the closing stock price divided by the sum of the last 12 months actual EPS.
% EPS Growth – Past 3 year: Earnings per share refers to the bottom-line measure of a company’s profitability defined as net income divided by the number of outstanding shares.
Return on Equity: Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders' equity.
Forecasted P/E Ratio: a measure of the P/E (price-to-earnings) ratio using forecasted earnings for the P/E calculation.
Projected Earnings Growth Rate: The expected EPS growth over the next 3-5 years calculated by FactSet from data provided by brokers.
2587304